Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0092205
Title: Impact of pay for performance on prescribing of long- Acting reversible contraception in primary care: An interrupted time series study
Authors: Arrowsmith M.E.
Majeed A.
Lee J.T. 
Saxena S.
Keywords: oral contraceptive agent
spermicidal agent
contraceptive agent
adolescent
adult
article
contraception
female
general practice
health insurance
hormonal contraception
human
intrauterine contraceptive device
long acting reversible contraception
oral contraception
prescription
primary medical care
time series analysis
uterine cervix cap
vagina ring
controlled study
economics
organization and management
primary health care
randomized controlled trial
reimbursement
Adolescent
Adult
Contraceptive Agents, Female
Female
Humans
Primary Health Care
Reimbursement, Incentive
Issue Date: 2014
Citation: Arrowsmith M.E., Majeed A., Lee J.T., Saxena S. (2014). Impact of pay for performance on prescribing of long- Acting reversible contraception in primary care: An interrupted time series study. PLoS ONE 9 (4) : e92205. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0092205
Rights: Attribution 4.0 International
Abstract: Background: The aim of this study was to evaluate the impact of Quality and Outcomes Framework (QOF), a major pay-forperformance programme in the United Kingdom, on prescribing of long-acting reversible contraceptives (LARC) in primary care. Methods: Negative binomial interrupted time series analysis using practice level prescribing data from April 2007 to March 2012. The main outcome measure was the prescribing rate of long-acting reversible contraceptives (LARC), including hormonal and non hormonal intrauterine devices and systems (IUDs and IUSs), injectable contraceptives and hormonal implants. Results: Prescribing rates of Long-Acting Reversible Contraception (LARC) were stable before the introduction of contraceptive targets to the QOF and increased afterwards by 4% annually (rate ratios = 1.04, 95% CI = 1.03, 1.06). The increase in LARC prescribing was mainly driven by increases in injectables (increased by 6% annually), which was the most commonly prescribed LARC method. Of other types of LARC, the QOF indicator was associated with a step increase of 20% in implant prescribing (RR = 1.20, 95% CI = 1.09, 1.32). This change is equivalent to an additional 110 thousand women being prescribed with LARC had QOF points not been introduced. Conclusions: Pay for performance incentives for contraceptive counselling in primary care with women seeking contraceptive advice has increased uptake of LARC methods. © 2014 Arrowsmith et al.
Source Title: PLoS ONE
URI: https://scholarbank.nus.edu.sg/handle/10635/161422
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0092205
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0092205.pdf379.45 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons